Gsk (GSK) Other Gross PP&E Adjustments (2019 - 2025)
Historic Other Gross PP&E Adjustments for Gsk (GSK) over the last 7 years, with Q3 2025 value amounting to -$1.1 billion.
- Gsk's Other Gross PP&E Adjustments rose 235.15% to -$1.1 billion in Q3 2025 from the same period last year, while for Sep 2025 it was -$1.1 billion, marking a year-over-year increase of 235.15%. This contributed to the annual value of -$1.1 billion for FY2024, which is 721.1% up from last year.
- Gsk's Other Gross PP&E Adjustments amounted to -$1.1 billion in Q3 2025, which was up 235.15% from -$1.1 billion recorded in Q2 2025.
- In the past 5 years, Gsk's Other Gross PP&E Adjustments ranged from a high of -$134.2 million in Q1 2022 and a low of -$1.2 billion during Q4 2023
- Its 5-year average for Other Gross PP&E Adjustments is -$944.8 million, with a median of -$1.0 billion in 2025.
- In the last 5 years, Gsk's Other Gross PP&E Adjustments skyrocketed by 8769.78% in 2022 and then tumbled by 49424.14% in 2023.
- Gsk's Other Gross PP&E Adjustments (Quarter) stood at -$997.5 million in 2021, then grew by 19.22% to -$805.8 million in 2022, then crashed by 44.32% to -$1.2 billion in 2023, then increased by 6.63% to -$1.1 billion in 2024, then rose by 1.85% to -$1.1 billion in 2025.
- Its Other Gross PP&E Adjustments was -$1.1 billion in Q3 2025, compared to -$1.1 billion in Q2 2025 and -$1.0 billion in Q1 2025.